Ferulic acid: Pharmacological and toxicological aspects

Food and Chemical Toxicology

Volumn 65, Issue , 2014, Pages 185-195

  Mancuso, Cesare ^a   Santangelo, Rosaria ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Aging; Biliverdin reductase; Ferulic acid; Free radicals; Heme oxygenase; Neurodegenerative disorders

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA TOCOPHEROL; AMINO ACID DERIVATIVE; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARBOPLATIN; CASPASE; CISPLATIN; CYCLOOXYGENASE 2; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FERULIC ACID; FLUOROURACIL; GLYCERYL TRINITRATE; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NIOSOME; NITRATE; PROTEIN KINASE B; SCAVENGER; SOLID LIPID NANOPARTICLE; BILIVERDIN REDUCTASE; CATALASE; OXIDOREDUCTASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANGINA PECTORIS; ANTICOAGULATION; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; CARCINOGENICITY; CARDIOVASCULAR DISEASE; CELL PROTECTION; CELLULAR STRESS RESPONSE; COGNITIVE DEFECT; DIABETES MELLITUS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENTIATION; DRUG RESEARCH; DRUG STRUCTURE; ENZYME INHIBITION; GASTROINTESTINAL HEMORRHAGE; GENOTOXICITY; HEART ARRHYTHMIA; HEART PROTECTION; HUMAN; HYPERTENSION; INTRACOLONIC DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; LACRIMATION; LIVER PROTECTION; MAXIMUM PLASMA CONCENTRATION; NEUROPROTECTION; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; REFLEX; REVIEW; SINGLE DRUG DOSE; SKIN PROTECTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; STRUCTURE ANALYSIS; TIME TO MAXIMUM PLASMA CONCENTRATION; UNSPECIFIED SIDE EFFECT; UPREGULATION; ANTIHYPERTENSIVE THERAPY; ANTINEOPLASTIC ACTIVITY; BREAST TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; COLITIS; COLON TUMOR; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; DRUG MECHANISM; DYSPLASIA; EHRLICH ASCITES TUMOR; ERYTHEMA; HEART ARREST; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HYPERPIGMENTATION; HYPERPLASIA; LUNG TUMOR; NEUROTOXICITY; SARCOMA; TONGUE CARCINOMA; TOXICITY TESTING;

AGING; BILIVERDIN REDUCTASE; FERULIC ACID; FREE RADICALS; HEME OXYGENASE; NEURODEGENERATIVE DISORDERS;

ALZHEIMER DISEASE; CARDIOVASCULAR DISEASES; COUMARIC ACIDS; DIABETES MELLITUS; HUMANS; NEOPLASMS; SKIN DISEASES;

EID: 84892632782     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.12.024     Document Type: Review

References (135)

1. Adisakwattana S., Chantarasinlapin P., Thammarat H., Yibchok-Anun S. A series of cinnamic acid derivatives and their inhibitory activity on intestinal alpha-glucosidase. J. Enzyme Inhib. Med. Chem. 2009, 24:1194-1200.
2. Adluri R.S., Nagarajan D., Periyaswamy V., Venugopal P.M. Dose-response effect of ferulic acid against nicotine-induced tissue damage and altered lipid levels in experimental rats: a pathohistological evaluation. Fundam. Clin. Pharmacol. 2008, 22:557-567.
3. Alam M.A., Sernia C., Brown L. Ferulic acid improves cardiovascular and kidney structure and function in hypertensive rats. J. Cardiovasc. Pharmacol. 2013, 61:240-249.
4. Anantharaman M., Tangpong J., Keller J.N., Murphy M.P., Markesbery W.R., Kiningham K.K., St Clair D.K. Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease. Am. J. Pathol. 2006, 168:1608-1618.
5. Ardiansyah, Ohsaki Y., Shirakawa H., Koseki T., Komai M. Novel effects of a single administration of ferulic acid on the regulation of blood pressure and the hepatic lipid metabolic profile in stroke-prone spontaneously hypertensive rats. J. Agric. Food Chem. 2008, 56:2825-2830.
6. Azzini E., Bugianesi R., Romano F., Di Venere D., Miccadei S., Durazzo A., Foddai M.S., Catasta G., Linsalata V., Maiani G. Absorption and metabolism of bioactive molecules after oral consumption of cooked edible heads of Cynara scolymus L. (cultivar Violetto di Provenza) in human subjects: a pilot study. Br. J. Nutr. 2007, 97:963-969.
7. Badawy D., El-Bassossy H.M., Fahmy A., Azhar A. Aldose reductase inhibitors zopolrestat and ferulic acid alleviate hypertension associated with diabetes: effect on vascular reactivity. Can. J. Physiol. Pharmacol. 2013, 91:101-107.
8. Balakrishnan S., Menon V.P., Manoharan S., Rajalingam K. Antigenotoxic effect of ferulic acid in 7,12-dimethyl benz(a)-anthracene (DMBA) induced genotoxicity. Afr. J. Tradit. Complement. Altern. Med. 2007, 5:32-38.
9. Ballard C., Gauthier S., Corbett A., Brayne C., Aarsland D., Jones E. Alzheimer's disease. Lancet 2011, 377:1019-1031.
10. Bandugula V.R., Prasad N.R. 2-Deoxy-d-glucose and ferulic acid modulates radiation response signaling in non-small cell lung cancer cells. Tumour Biol. 2013, 34:251-259.
11. Barone E., Calabrese V., Mancuso C. Ferulic acid and its therapeutic potential as a hormetin for age-related diseases. Biogerontology 2009, 10:97-108.
12. Baskaran N., Manoharan S., Balakrishnan S., Pugalendhi P. Chemopreventive potential of ferulic acid in 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in Sprague-Dawley rats. Eur. J. Pharmacol. 2010, 637:22-29.
13. Bayer T.A., Schäfer S., Breyhan H., Wirths O., Treiber C., Multhaup G. A vicious circle: role of oxidative stress, intraneuronal Abeta and Cu in Alzheimer's disease. Clin. Neuropathol. 2006, 25:163-171.
14. Belicová A., Krizková L., Nagy M., Krajcovic J., Ebringer L. Phenolic acids reduce the genotoxicity of acridine orange and ofloxacin in Salmonella typhimurium. Folia Microbiol. (Praha) 2001, 46:511-514.
15. Bourne L.C., Rice-Evans C. Bioavailability of ferulic acid. Biochem. Biophys. Res. Commun. 1998, 253:222-277.
16. Butterfield D.A., Reed T., Newman S.F., Sultana R. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic. Biol. Med. 2007, 43:658-677.
17. Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D.A., Stella A.M. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 2007, 8:766-775.
18. Calabrese V., Calafato S., Puleo E., Cornelius C., Sapienza M., Morganti P., Mancuso C. Redox regulation of cellular stress response by ferulic acid ethyl ester in human dermal fibroblasts: role of vitagenes. Clin. Dermatol. 2008, 26:358-363.
19. Cassano R., Trombino S., Cilea A., Ferrarelli T., Muzzalupo R., Picci N. l-lysine pro-prodrug containing trans-ferulic acid for 5-amino salicylic acid colon delivery: synthesis, characterization and in vitro antioxidant activity evaluation. Chem. Pharm. Bull. (Tokyo) 2010, 58:103-105.
20. Cheng C.Y., Su S.Y., Tang N.Y., Ho T.Y., Lo W.Y., Hsieh C.L. Ferulic acid inhibits nitric oxide-induced apoptosis by enhancing GABA(B1) receptor expression in transient focal cerebral ischemia in rats. Acta Pharmacol. Sin. 2010, 31:889-899.
21. Cho J.Y., Kim H.S., Kim D.H., Jan J.J., Suh H.W., Song D.K. Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice. Prog. Neuropsychopharmacol. Biol. Psychiatr. 2005, 29:901-907.
22. Choi R., Kim B.H., Naowaboot J., Lee M.Y., Hyun M.R., Cho E.J., Lee E.S., Lee E.Y., Yang Y.C., Chung C.H. Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes. Exp. Mol. Med. 2011, 43:676-683.
23. Clifford M.N. Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden. J. Sci. Food Agric. 1999, 79:362-372.
24. Couteau D., McCartney A.L., Gibson G.R., Williamson G., Faulds C.B. Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid. J. Appl. Microbiol. 2001, 90:873-881.
25. Cuzick J., Otto F., Baron J.A., Brown P.H., Burn J., Greenwald P., Jankowski J., La Vecchia C., Meyskens F., Senn H.J., Thun M. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol. 2009, 10:501-507.
26. D'Archivio M., Filesi C., Di Benedetto R., Gargiulo R., Giovannini C., Masella R. Polyphenols, dietary sources and bioavailability. Ann. Ist. Super. Sanita 2007, 43:348-361.
27. Dong W.G., Liu S.P., Yu B.P., Wu D.F., Luo H.S., Yu J.P. Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats. World J. Gastroenterol. 2003, 9:2533-2538.
28. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2009. Scientific opinion on the substantiation of health claims related to Angelica sinensis (Oliv.) Diels. and maintenance of joints (ID 2392) and oxygen transport (ID 3845) pursuant to Article 13(1) of Regulation (EC) No. 1924/2006. EFSA J. 7, 1281.
29. Evans C.G., Chang L., Gestwicki J.E. Heat shock protein 70 (hsp70) as an emerging drug target. J. Med. Chem. 2010, 53:4585-4602.
30. Ferguson L.R., Zhu S.T., Harris P.J. Antioxidant and antigenotoxic effects of plant cell wall hydroxycinnamic acids in cultured HT-29 cells. Mol. Nutr. Food Res. 2005, 49:585-593.
31. Ferrer I. Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease. J. Bioenerg. Biomembr. 2009, 41:425-431.
32. Fetoni A.R., Mancuso C., Eramo S.L., Ralli M., Piacentini R., Barone E., Paludetti G., Troiani D. In vivo protective effect of ferulic acid against noise-induced hearing loss in the guinea-pig. Neuroscience 2010, 169:1575-1588.
33. Fridovich I. Fundamental aspects of reactive oxygen species, or what's the matter with oxygen?. Ann. NY Acad. Sci. 1999, 893:13-18.
34. Fuchs J., Kern H. Modulation of UV-light-induced skin inflammation by d-alpha-tocopherol and l-ascorbic acid: a clinical study using solar simulated radiation. Free Radic. Biol. Med. 1998, 25:1006-1012.
35. Fujita A., Sasaki H., Doi A., Okamoto K., Matsuno S., Furuta H., Nishi M., Nakao T., Tsuno T., Taniguchi H., Nanjo K. Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats. Diabetes Res. Clin. Pract. 2008, 79:11-17.
36. Garrido C., Paul C., Seigneuric R., Kampinga H.H. The small heat shock proteins family: the long forgotten chaperones. Int. J. Biochem. Cell Biol. 2012, 44:1588-1592.
37. Giacchetti G., Sechi L.A., Rilli S., Carey R.M. The renin-angiotensin-aldosterone system, glucose metabolism and diabetes. Trends Endocrinol. Metab. 2005, 16:120-126.
38. Graf E. Antioxidant potential of ferulic acid. Free Radic. Biol. Med. 1992, 13:435-448.
39. Grothe M., Zaborszky L., Atienza M., Gil-Neciga E., Rodriguez-Romero R., Teipel S.J., Amunts K., Suarez-Gonzalez A., Cantero J.L. Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease. Cereb. Cortex. 2010, 20:1685-1695.
40. Halliwell B. Biochemical mechanisms accounting for the toxic action of oxygen on living organisms: the key role of superoxide dismutase. Cell Biol. Int. Rep. 1978, 2:113-128.
41. Hemaiswarya S., Doble M. Combination of phenylpropanoids with 5-fluorouracil as anti-cancer agents against human cervical cancer (HeLa) cell line. Phytomedicine 2013, 20:151-158.
42. Henderson B. Integrating the cell stress response: a new view of molecular chaperones as immunological and physiological homeostatic regulators. Cell Biochem. Funct. 2010, 28:1-14.
43. Indap M.A., Radhika S., Motiwale L., Rao K.V. Inhibitory effect of cinnamoyl compounds against human malignant cell line. Indian J. Exp. Biol. 2006, 44:216-220.
44. Inoguchi T., Sonta T., Tsubouchi H., Etoh T., Kakimoto M., Sonoda N., Sato N., Sekiguchi N., Kobayashi K., Sumimoto H., Utsumi H., Nawata H. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J. Am. Soc. Nephrol. 2003, 14:S227-S232.
45. Janicke B., Hegardt C., Krogh M., Onning G., Akesson B., Cirenajwis H.M., Oredsson S.M. The antiproliferative effect of dietary fiber phenolic compounds ferulic acid and p-coumaric acid on the cell cycle of Caco-2 cells. Nutr. Cancer 2011, 63:611-622.
46. Jayaprakasam B., Vanisree M., Zhang Y., Dewitt D.L., Nair M.G. Impact of alkyl esters of caffeic and ferulic acids on tumor cell proliferation, cyclooxygenase enzyme, and lipid peroxidation. J. Agric. Food Chem. 2006, 54:5375-5381.
47. Jin Y., Yan E.Z., Fan Y., Zong Z.H., Qi Z.M., Li Z. Sodium ferulate prevents amyloid-beta-induced neurotoxicity through suppression of p38 MAPK and upregulation of ERK-1/2 and Akt/protein kinase B in rat hippocampus. Acta Pharmacol. Sin. 2005, 26:943-951.
48. Jin Y., Fan Y., Yan E.Z., Liu Z., Zong Z.H., Qi Z.M. Effects of sodium ferulate on amyloid-beta-induced MKK3/MKK6-p38 MAPK-Hsp27 signal pathway and apoptosis in rat hippocampus. Acta Pharmacol. Sin. 2006, 27:1309-1316.
49. Jin Y., Yan E.Z., Li X.M., Fan Y., Zhao Y.J., Liu Z., Liu W.Z. Neuroprotective effect of sodium ferulate and signal transduction mechanisms in the aged rat hippocampus. Acta Pharmacol. Sin. 2008, 29:1399-1408.
50. Joshi G., Perluigi M., Sultana R., Agrippino R., Calabrese V., Butterfield D.A. In vivo protection of synaptosomes by ferulic acid ethyl ester (FAEE) from oxidative stress mediated by 2,2-azobis(2-amidino-propane)dihydrochloride (AAPH) or Fe(2+)/H(2)O(2): insight into mechanisms of neuroprotection and relevance to oxidative stress-related neurodegenerative disorders. Neurochem. Int. 2006, 48:318-327.
51. Jung E.H., Kim S.R., Hwang I.K., Ha T.Y. Hypoglycemic effects of a phenolic acid fraction of rice bran and ferulic acid in C57BL/KsJ-db/db mice. J. Agric. Food Chem. 2007, 55:9800-9804.
52. Kanski J., Aksenova M., Stoyanova A., Butterfield D.A. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J. Nutr. Biochem. 2002, 13:273-281.
53. Karthikeyan S., Kanimozhi G., Prasad N.R., Mahalakshmi R. Radiosensitizing effect of ferulic acid on human cervical carcinoma cells in vitro. Toxicol. In Vitro 2011, 25:1366-1375.
54. Katsuki H., Nakai S., Hirai Y., Akaji K., Kiso Y., Satoh M. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur. J. Pharmacol. 1990, 181:323-326.
55. Keeney J.T., Swomley A.M., Harris J.L., Fiorini A., Mitov M.I., Perluigi M., Sultana R., Butterfield D.A. Cell cycle proteins in brain in mild cognitive impairment: insights into progression to Alzheimer disease. Neurotox. Res. 2012, 22:220-230.
56. Kern S.M., Bennett R.N., Mellon F.A., Kroon P.A., Garcia-Conesa M.T. Absorption of hydroxycinnamates in humans after high-bran cereal consumption. J. Agric. Food Chem. 2003, 51:6050-6055.
57. Khanduja K.L., Avti P.K., Kumar S., Mittal N., Sohi K.K., Pathak C.M. Anti-apoptotic activity of caffeic acid, ellagic acid and ferulic acid in normal human peripheral blood mononuclear cells: a Bcl-2 independent mechanism. Biochim. Biophys. Acta 2006, 1760:283-289.
58. Kim M.J., Choi S.J., Lim S.T., Kim H.K., Heo H.J., Kim E.K., Jun W.J., Cho H.Y., Kim Y.J., Shin D.H. Ferulic acid supplementation prevents trimethyltin-induced cognitive deficits in mice. Biosci. Biotechnol. Biochem. 2007, 71:1063-1068.
59. Kiritoshi S., Nishikawa T., Sonoda K., Kukidome D., Senokuchi T., Matsuo T., Matsumura T., Tokunaga H., Brownlee M., Araki E. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 2003, 52:2570-2577.
60. Koh P.O. Ferulic acid modulates nitric oxide synthase expression in focal cerebral ischemia. Lab. Anim. Res. 2012, 28:273-278.
61. Kroon P.A., Faulds C.B., Ryden P., Robertson J.A., Williamson G. Release of covalently bound ferulic acid from fiber in the human colon. J. Agric. Food Chem. 1997, 45:661-667.
62. Kundu J.K., Surh Y.J. Inflammation: gearing the journey to cancer. Mutat. Res. 2008, 659:15-30.
63. Kwon E.Y., Cho Y.Y., Do G.M., Kim H.J., Jeon S.M., Park Y.B., Lee M.K., Min T.S., Choi M.S. Actions of ferulic acid and vitamin E on prevention of hypercholesterolemia and atherogenic lesion formation in apolipoprotein E-deficient mice. J. Med. Food 2009, 12:996-1003.
64. Kwon E.Y., Do G.M., Cho Y.Y., Park Y.B., Jeon S.M., Choi M.S. Anti-atherogenic property of ferulic acid in apolipoprotein E-deficient mice fed Western diet: comparison with clofibrate. Food Chem. Toxicol. 2010, 48:2298-2303.
65. Li R., Yang L., Lindholm K., Konishi Y., Yue X., Hampel H., Zhang D., Shen Y. Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death. J. Neurosci. 2004, 24:1760-1771.
66. Li F., Cao Q.E., Ding Z. Separation and determination of three phenylpropanoids in the traditional Chinese medicine and its preparations by capillary electrophoresis. J. Chromatogr. Sci. 2007, 45(6):354-359.
67. Li F.Q., Su H., Wang J., Liu J.Y., Zhu Q.G., Fei Y.B., Pan Y.H., Hu J.H. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting. Int. J. Pharm. 2008, 349:274-282.
68. Li X., Shang L., Wu Y., Abbas S., Li D., Netter P., Ouzzine M., Wang H., Magdalou J. Identification of the human UDP-glucuronosyltransferase isoforms involved in the glucuronidation of the phytochemical ferulic acid. Drug Metab. Pharmacokinet. 2011, 26:341-350.
69. Lin F.H., Lin J.Y., Gupta R.D., Tournas J.A., Burch J.A., Selim M.A., Monteiro-Riviere N.A., Grichnik J.M., Zielinski J., Pinnell S.R. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. J. Invest. Dermatol. 2005, 125:826-832.
70. Ma Z.C., Hong Q., Wang Y.G., Liang Q.D., Tan H.L., Xiao C.R., Tang X.L., Shao S., Zhou S.S., Gao Y. Ferulic acid induces heme oxygenase-1 via activation of ERK and Nrf2. Drug Discov. Ther. 2011, 5:299-305.
71. Maines M.D. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 1997, 37:517-554.
72. Mamiya T., Kise M., Morikawa K. Ferulic acid attenuated cognitive deficits and increase in carbonyl proteins induced by buthionine-sulfoximine in mice. Neurosci. Lett. 2008, 430:115-118.
73. Mancuso C., Bonsignore A., Di Stasio E., Mordente A., Motterlini R. Bilirubin and S-nitrosothiols interaction: evidence for a possible role of bilirubin as a scavenger of nitric oxide. Biochem. Pharmacol. 2003, 66:2355-2363.
74. Mancuso C., Bonsignore A., Capone C., Di Stasio E., Pani G. Albumin-bound bilirubin interacts with nitric oxide by a redox mechanism. Antioxid. Redox. Signal. 2006, 8:487-494.
75. Mancuso C., Barone E. The heme oxygenase/biliverdin reductase pathway in drug research and development. Curr. Drug Metab. 2009, 10:579-594.
76. Mancuso C., Barone E., Guido P., Miceli F., Di Domenico F., Perluigi M., Santangelo R., Preziosi P. Inhibition of lipid peroxidation and protein oxidation by endogenous and exogenous antioxidants in rat brain microsomes in vitro. Neurosci. Lett. 2012, 518:101-105.
77. Menter D.G., Schilsky R.L., DuBois R.N. Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin. Cancer Res. 2010, 16:1384-1390.
78. Minetti M., Mallozzi C., Di Stasi A.M., Pietraforte D. Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. Arch. Biochem. Biophys. 1998, 352:165-174.
79. Mori T., Koyama N., Guillot-Sestier M.V., Tan J., Town T. Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic mice. PLoS ONE 2013, 8:e55774.
80. Mulinacci N., Prucher D., Peruzzi M., Romani A., Pinelli P., Giaccherini C., Vincieri F.F. Commercial and laboratory extracts from artichoke leaves: estimation of caffeoyl esters and flavonoidic compounds content. J. Pharm. Biomed. Anal. 2004, 34:349-357.
81. Nair S.C., Panikkar B., Akamanchi K.G., Panikkar K.R. Inhibitory effects of Ixora javanica extract on skin chemical carcinogenesis in mice and its antitumour activity. Cancer Lett. 1991, 60:253-258.
82. Naudi A., Jove M., Ayala V., Cassanye A., Serrano J., Gonzalo H., Boada J., Prat J., Portero-Otin M., Pamplona R. Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress. Exp. Diabetes Res. 2012, 2012:696215.
83. Ou S., Kwok K.C. Ferulic acid: pharmaceutical functions, preparation and applications in food. J. Sci. Food Agric. 2004, 84:1261-1269.
84. Pagidipati N.J., Gaziano T.A. Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement. Circulation 2013, 127:749-756.
85. Pannala A.S., Razaq R., Halliwell B., Singh S., Rice-Evans C.A. Inhibition of peroxynitrite dependent tyrosine nitration by hydroxycinnamates: nitration or electron donation?. Free Radic. Biol. Med. 1998, 24:594-606.
86. Perluigi M., Joshi G., Sultana R., Calabrese V., De Marco C., Coccia R., Cini C., Butterfield D.A. In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress. J. Neurosci. Res. 2006, 84:418-426.
87. Picone P., Bondi M.L., Montana G., Bruno A., Pitarresi G., Giammona G., Di Carlo M. Ferulic acid inhibits oxidative stress and cell death induced by Ab oligomers: improved delivery by solid lipid nanoparticles. Free Radic. Res. 2009, 43:1133-1145.
88. Poquet L., Clifford M.N., Williamson G. Transport and metabolism of ferulic acid through the colonic epithelium. Drug Metab. Dispos. 2008, 36:190-197.
89. Prabhakar P.K., Prasad R., Ali S., Doble M. Synergistic interaction of ferulic acid with commercial hypoglycemic drugs in streptozotocin induced diabetic rats. Phytomedicine 2013, 20:488-494.
90. Preziosi P., Loscalzo B., Bianchi A. Pharmacodynamic research on the active principle of Cynara scolimus (1,4-dicaffeiylquinic acid): effect on choleresis. Boll. Soc. Ital. Biol. Sper. 1957, 33:672-674.
91. Preziosi P., Loscalzo B. Pharmacodynamic research on the active principle of Cynara scolimus (1,4-dicaffeiylquinic acid): effect on blood cholesterol values & on triton-induced hypercholesterolemia. Boll. Soc. Ital. Biol. Sper. 1957, 33:679-682.
92. Preziosi P., Loscalzo B. Experimental evaluation of 1,4-dicaffeiylquinic acid, the active principle of artichoke. Arch. Ital. Sci. Farmacol. 1957, 7:249-296.
93. Preziosi P., Loscalzo B. Pharmacological properties of 1,4 dicaffeylquinic acid, the active principle of Cynara scolimus. Arch. Int. Pharmacodyn. Ther. 1958, 117:63-80.
94. Qin J., Chen D., Hu H. Body distributioin of RGD-mediated liposome in brain-targeting drug delivery. Yakugaku Zasshi 2007, 127:1497-1501.
95. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N. Engl. J. Med. 2010, 362:329-344.
96. Rabacchi S.A., Friedman W.J., Shelanski M.L., Troy C.M. Divergence of the apoptotic pathways induced by 4-hydroxynonenal and amyloid beta-protein. Neurobiol. Aging 2004, 25:1057-1066.
97. Ramar M., Manikandan B., Raman T., Priyadarsini A., Palanisamy S., Velayudam M., Munusamy A., Marimuthu Prabhu N., Vaseeharan B. Protective effect of ferulic acid and resveratrol against alloxan-induced diabetes in mice. Eur. J. Pharmacol. 2012, 690:226-235.
98. Rechner A.R., Pannala A.S., Rice-Evans C.A. Caffeic acid derivatives in artichoke extract are metabolised to phenolic acids in vivo. Free Radic. Res. 2001, 35:195-202.
99. Reiter C.D., Teng R.J., Beckman J.S. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J. Biol. Chem. 2000, 275:32460-32466.
100. Rhein V., Eckert A. Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function - role of glucose metabolism and insulin signalling. Arch. Physiol. Biochem. 2007, 113:131-141.
101. Rolo A.P., Palmeira C.M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol. 2006, 212:167-178.
102. Rondini L., Peyrat-Maillard M.N., Marsset-Baglieri A., Berset C. Sulfated ferulic acid is the main in vivo metabolite found after short-term ingestion of free ferulic acid in rats. J. Agric. Food Chem. 2002, 50:3037-3041.
103. Rondini L., Peyrat-Maillard M.N., Marsset-Baglieri A., Fromentin G., Durand P., Tomé D., Prost M., Berset C. Bound ferulic acid from bran is more bioavailable than the free compound in rat. J. Agric. Food Chem. 2004, 52:4338-4343.
104. Roy S., Metya S.K., Sannigrahi S., Rahaman N., Ahmed F. Treatment with ferulic acid to rats with streptozotocin-induced diabetes: effects on oxidative stress, pro-inflammatory cytokines, and apoptosis in the pancreatic β cell. Endocrine 2013, 44:369-379.
105. Saija A., Tomaino A., Trombetta D., De Pasquale A., Uccella N., Barbuzzi T., Paolino D., Bonina F. In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents. Int. J. Pharm. 2000, 199:39-47.
106. Saulnier L., Vigouroux J., Thibault J.F. Isolation and partial characterization of feruloylated oligosaccharides from maize bran. Carbohydr. Res. 1995, 272:241-253.
107. Scapagnini G., Butterfield D.A., Colombrita C., Sultana R., Pascale A., Calabrese V. Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxid. Redox Signal. 2004, 6:811-818.
108. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 1997, 17:2653-2657.
109. Srinivasan M., Rukkumani R., Ram Sudheer A., Menon V.P. Ferulic acid, a natural protector against carbon tetrachloride-induced toxicity. Fundam. Clin. Pharmacol. 2005, 19:491-496.
110. Stagos D., Spanou C., Margariti M., Stathopoulos C., Mamuris Z., Kazantzoglou G., Magiatis P., Kouretas D. Cytogenetic effects of grape extracts (Vitis vinifera) and polyphenols on mitomycin C-induced sister chromatid exchanges (SCEs) in human blood lymphocytes. J. Agric. Food Chem. 2007, 55:5246-5252.
111. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235:1043-1046.
112. Stocker R., Glazer A.N., Ames B.N. Antioxidant activity of albumin-bound bilirubin. Proc. Natl. Acad. Sci. USA 1987, 84:5918-5922.
113. Sudheer A.R., Muthukumaran S., Kalpana C., Srinivasan M., Menon V.P. Protective effect of ferulic acid on nicotine-induced DNA damage and cellular changes in cultured rat peripheral blood lymphocytes: a comparison with N-acetylcysteine. Toxicol. In Vitro 2007, 21:576-585.
114. Sultana R., Ravagna A., Mohmmad-Abdul H., Calabrese V., Butterfield D.A. Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J. Neurochem. 2005, 92:749-758.
115. Sultana R., Butterfield D.A. Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment. J. Bioenerg. Biomembr. 2009, 41:441-446.
116. Suzuki A., Kagawa D., Fujii A., Ochiai R., Tokimitsu I., Saito I. Short- and long-term effects of ferulic acid on blood pressure in spontaneously hypertensive rats. Am. J. Hypertens. 2002, 15:351-357.
117. Suzuki A., Yamamoto M., Jokura H., Fujii A., Tokimitsu I., Hase T., Saito I. Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats. Am. J. Hypertens. 2007, 20:508-513.
118. Tada, Y., Tayama, K., Aoki, N., 1999. Acute oral toxicity of ferulic acid, natural food additive, in rats. Ann. Rep. Tokyo Metr. Lab. P.H. 50, 311-313.
119. Tanaka T., Kojima T., Kawamori T., Wang A., Suzui M., Okamoto K., Mori H. Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis 1993, 14:1321-1325.
120. Trombino S., Cassano R., Muzzalupo R., Pingitore A., Cione E., Picci N. Stearyl ferulate-based solid lipid nanoparticles for the encapsulation and stabilization of beta-carotene and alpha-tocopherol. Colloids Surf. B: Biointerf. 2009, 72:181-187.
121. Trombino S., Cassano R., Ferrarelli T., Barone E., Picci N., Mancuso C. Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes. Colloids Surf. B: Biointerf. 2013, 109:273-279.
122. van der Logt E.M., Roelofs H.M., Nagengast F.M., Peters W.H. Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis 2003, 24:1651-1656.
123. Wang B., Ou-Yang J., Liu Y., Yang J., Wei L., Li K., Yang H. Sodium ferulate inhibits atherosclerogenesis in hyperlipidemia rabbits. J. Cardiovasc. Pharmacol. 2004, 43:549-554.
124. Wang B.H., Ou-Yang J.P. Pharmacological actions of sodium ferulate in cardiovascular system. Cardiovasc. Drug Rev. 2005, 23:161-172.
125. West J.D., Wang Y., Morano K.A. Small molecule activators of the heat shock response: chemical properties, molecular targets, and therapeutic promise. Chem. Res. Toxicol. 2012, 25:2036-2053.
126. Xu X., Xiao H., Zhao J., Zhao T. Cardioprotective effect of sodium ferulate in diabetic rats. Int. J. Med. Sci. 2012, 9:291-300.
127. Yan J.J., Cho J.Y., Kim H.S., Kim K.L., Jung J.S., Huh S.O., Suh H.W., Kim Y.H., Song D.K. Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br. J. Pharmacol. 2001, 133:89-96.
128. Yan J.J., Jung J.S., Kim T.K., Hasan A., Hong C.W., Nam J.S., Song D.K. Protective effects of ferulic acid in amyloid precursor protein plus presenilin-1 transgenic mouse model of Alzheimer disease. Biol. Pharm. Bull. 2013, 36:140-143.
129. Yang C., Tian Y., Zhang Z., Xu F., Chen Y. High-performance liquid chromatography-electrospray ionization mass spectrometry determination of sodium ferulate in human plasma. J. Pharm. Biomed. Anal. 2007, 43:945-950.
130. Yi L., Liang Y., Wu H., Yuan D. The analysis of Radix Angelicae Sinensis (Danggui). J. Chromatogr. A 2009, 1216:1991-2001.
131. Zhao Z., Egashira Y., Sanada H. Ferulic acid sugar esters are recovered in rat plasma and urine mainly as the sulfoglucuronide of ferulic acid. J. Nutr. 2003, 133:1355-1361.
132. Zhao Z., Egashira Y., Sanada H. Ferulic acid is quickly absorbed from rat stomach as the free form and then conjugated mainly in liver. J. Nutr. 2004, 134:3083-3088.
133. Zhao Z., Moghadasian M.H. Chemistry, natural sources, dietary intake and pharmacokinetic properties of ferulic acid: a review. Food Chem. 2008, 109:691-702.
134. Zheng R.L., Zhang H. Effects of ferulic acid on fertile and asthenozoospermic infertile human sperm motility, viability, lipid peroxidation, and cyclic nucleotides. Free Radic. Biol. Med. 1997, 22:581-586.
135. Zuiderweg E.R., Bertelsen E.B., Rousaki A., Mayer M.P., Gestwicki J.E., Ahmad A. Allostery in the Hsp70 chaperone proteins. Top Curr. Chem. 2013, 328:99-153.